Stress Urinary Incontinence Clinical Trial
Official title:
Effectiveness of Pelvic Floor Muscle Training Including 360 Degree Expanded Diaphragm Exercises in Women With Stress Urinary Incontinence: Double-Blind Randomized Controlled Study
This study was planned to examine and compare the effects of standard diaphragm exercises with Pelvic floor muscle exercises (PFME) and 360-degree expanded diaphragm exercises with PFME on urinary symptoms, PFM functions and quality of life in women with stress urinary incontinence.
Status | Recruiting |
Enrollment | 74 |
Est. completion date | December 1, 2024 |
Est. primary completion date | June 1, 2024 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 62 Years |
Eligibility | Inclusion Criteria: - Being a woman, - Participating in the research voluntarily, - Being between the ages of 18-62, - Ability to read and write Turkish, - Not having any mental problems that would prevent cooperation and understanding, - Having a complaint of stress urinary incontinence or stress-predominant mixed urinary incontinence. Exclusion Criteria: - Having received pelvic floor training before, - Having a neurological disease, - Pelvic organ prolapse stage is stage 2 or higher, - Having fecal incontinence, - Being pregnant, - Lower extremity problems that may affect the pelvic structure (conditions such as lower extremity inequality, total hip arthroplasty) - Having an active lower urinary tract infection, - Having respiratory system diseases such as chronic obstructive pulmonary disease and asthma, - Having undergone hysterectomy surgery. |
Country | Name | City | State |
---|---|---|---|
Turkey | Izmir University of Economics | Izmir |
Lead Sponsor | Collaborator |
---|---|
Izmir University of Economics |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change of Pelvic floor muscle contraction during Valsalva | Pelvic floor muscle contraction during Valsalva will be evaluated with the NeuroTract Myoplus 4 PRO EMG device. A disposable, cylindrical endovaginal probe will be used to record pelvic floor muscle electromyographic activity. The evaluation will be carried out as stated in previous studies, and the women are told: "Take as deep a breath as possible, pinch your nose with your thumb and index finger and close your mouth, try to breathe out against the now closed respiratory system." instructions will be given. For a clearer understanding, the expression "pretend to strain" will also be used. The probe will be manually supported by the investigator throughout the testing procedure to prevent the pressure probe from moving and losing contact with the PTK during evaluation. 2 seconds of reflex PFM activity will be recorded in µV. | at baseline, at 8th week | |
Secondary | Change of urinary symptoms | The severity of women's incontinence will be questioned with the Incontinence Severity Index. | at baseline, at 8th week | |
Secondary | Change of quality of life score | Urinary incontinence symptoms and their impact on quality of life will be evaluated with the International Urinary Incontinence Questionnaire Form. | at baseline, at 8th week | |
Secondary | Change of Pelvic floor muscle maximum voluntary contraction | Maximum voluntary contraction of women will be evaluated with the NeuroTract Myoplus 4 PRO EMG device. A disposable, cylindrical endovaginal probe will be used to record pelvic floor muscle electromyographic activity. MVC, average peak activation results during three PFM contractions will be expressed in µV and percentage (%). | at baseline, at 8th week | |
Secondary | Change of maximum inspiratory pressure | A non-invasive, RP Check brand electronic pressure measuring device (MD Diagnostics Ltd., Maidstone, UK) will be used to measure maximum inspiratory pressure. | at baseline, at 8th week | |
Secondary | Change of maximum expiratory pressure | A non-invasive, RP Check brand electronic pressure measuring device (MD Diagnostics Ltd., Maidstone, UK) will be used to measure maximum expiratory pressure. | at baseline, at 8th week | |
Secondary | Subjective perception of improvement | Women's subjective perception of improvement was assessed using the Global Perception of Improvement scale | at 8th week | |
Secondary | Change of Social Activity Participation | The Social Activity Index will be used, in which nine social situations are selected to represent situations in which women have problems in social participation due to urinary incontinence. | at baseline, at 8th week | |
Secondary | Change of average number of urinary incontinence | Women will be asked to complete a bladder diary reflecting the daily activity patterns of the bladder for 3 consecutive days. | at baseline, at 8th week | |
Secondary | Change of Pelvic floor muscle strength | Vaginal palpation method will be used to measure pelvic floor muscle strength. (Modified Oxford Scale) | at baseline, at 8th week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04829357 -
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
|
||
Completed |
NCT05493735 -
Lidocaine for Pessary Check Pain Reduction
|
Phase 3 | |
Completed |
NCT04512053 -
A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence
|
Phase 2 | |
Active, not recruiting |
NCT06224335 -
Measurement of Intravaginal and Intra-abdominal Pressure and Pad Test During Sports Activities (SPORTVAGPRES)
|
||
Recruiting |
NCT05304312 -
The Role of Kegel Exercises Book to Improve Treatment in Stress Urinary Incontinence Women
|
N/A | |
Not yet recruiting |
NCT05527665 -
Sexual Fonction and Discomfort in Women After Midurethral Sling Surgery, Using PPSSQ
|
||
Not yet recruiting |
NCT04558762 -
Ten Years Follow-up After Insertion of a MUS (Mid Urethral Sling) Due to Stress Urinary Incontinence
|
||
Withdrawn |
NCT02524366 -
A Study of Transcorporal Versus Standard Artificial Urinary Sphincter Placement
|
N/A | |
Completed |
NCT01924728 -
Efficacy of Magnetic Stimulation for Stress Urinary Incontinence
|
N/A | |
Completed |
NCT01676662 -
Solace European Confirmatory Trial
|
N/A | |
Unknown status |
NCT01455779 -
Lyrette: Renewing Continence Objective and Subjective Efficacy Study
|
N/A | |
Terminated |
NCT01029106 -
Gynecare TVT Secur for the Management of Stress Urinary Incontinence (SUI)
|
N/A | |
Completed |
NCT01123096 -
Is the Cough Stress Test Equivalent to the 24 Hour Pad Test in the Assessment of Stress Incontinence?
|
N/A | |
Completed |
NCT01770691 -
Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence
|
N/A | |
Withdrawn |
NCT00573703 -
Laparoscopic Burch Colposuspension Versus Transobturatory Tape for the Treatment of Female Urinary Stress Incontinence
|
Phase 4 | |
Completed |
NCT00234754 -
Trans-Obturator Tape Versus Trans-Vaginal Tape for Stress Urinary Incontinence in Women
|
N/A | |
Completed |
NCT00441454 -
Retropubic vs. Transobturator Tension-free Vaginal Tape
|
N/A | |
Completed |
NCT03985345 -
Prospective Evaluation of the Connected EMY Biofeedback Probe in the Management of Stress Urinary Incontinence.
|
N/A | |
Active, not recruiting |
NCT03671694 -
Laser Vaginal Treatment for SUI
|
N/A | |
Completed |
NCT04097288 -
Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects
|
Phase 1 |